As expected, the levels of serum liver enzymes (ALT, AST, γ-GT, and ALP) and serum immunoglobulin (IgG, IgM, and IgA) were significantly higher in AIH patients than those in NAFLD and HC patients. This evidence concerns the gene CD79A and metabolic dysfunction-associated steatotic liver disease.